Analyst Rating Update on Align Technology (ALGN)

Align Technology (ALGN) : 8 brokerage houses believe that Align Technology (ALGN) is a Strong Buy at current levels. 1 Analyst considers the fundamentals to be worthy of a Buy recommendation. Zacks Investment Research suggests a Strong Buy with a rank of 1.The median of all the 9 Wall Street Analysts endorse the stock as a Strong Buy with a rating of 1.06.

Align Technology (ALGN) : Currently there are 8 street experts covering Align Technology (ALGN) stock. The most bullish and bearish price target for the stock is $115 and $82 respectively for the short term. The average price target of all the analysts comes to $95. The estimated standard deviation from the target is $10.14.

For this week, the average consensus of the company shares are rated as a Strong Buy.


Align Technology (NASDAQ:ALGN): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $90.52 and $90.02 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $92.04. The buying momentum continued till the end and the stock did not give up its gains. It closed at $91.95, notching a gain of 1.74% for the day. The total traded volume was 1,043,529 . The stock had closed at $90.38 on the previous day.

Align Technology, Inc. (Align) is a medical device company. The Company designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design and computer-aided manufacturing (CAD/CAM) digital services for dentistry, orthodontics, and dental records storage. The Company operates through two segments: Clear Aligner, known as the Invisalign system, and Scanners and Services, known as the iTero intraoral scanner and OrthoCAD services. The Companys Clear Aligner segment provides malocclusion and orthodontic treatment. The Companys Scanners and Services Segment offers iTero intraoral scanner, which utilizes laser and optical scanning to capture the contours of the patients dentition, gingival structures and the bite. It distributes products directly to customers, including orthodontists and general practitioner dentists (GPs), as well as to restorative dentists, including prosthodontists, periodontists and oral surgeons.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.